+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anergis SA - logo

Anergis SA is a clinical-stage biopharmaceutical company that develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Anergis SA was founded in 2001 and is based in Lausanne, Switzerland.

Global Allergy Immunotherapy Market Analysis 2019 - Product Thumbnail Image

Global Allergy Immunotherapy Market Analysis 2019

  • Report
  • October 2019
  • 129 Pages
From
From
From
From
Birch Pollen Allergy - Pipeline Insight, 2020 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Birch Pollen Allergy - Pipeline Review, H1 2020 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Review, H1 2020

  • Drug Pipelines
  • January 2020
  • 40 Pages
From
House Dust Mite Allergy - Pipeline Review, H1 2020 - Product Thumbnail Image

House Dust Mite Allergy - Pipeline Review, H1 2020

  • Drug Pipelines
  • January 2020
  • 58 Pages
From
Ragweed Pollen Allergy - Pipeline Review, H1 2020 - Product Thumbnail Image

Ragweed Pollen Allergy - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 35 Pages
From
From
From
From
Birch Pollen Allergy Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Birch Pollen Allergy Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • November 2018
  • 73 Pages
From
Pollen Allergy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pollen Allergy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • May 2018
  • 216 Pages
From
Loading Indicator
adroll